Gilead Sciences Inc (NAS:GILD)
$ 64.6 -0.34 (-0.52%) Market Cap: 80.48 Bil Enterprise Value: 100.96 Bil PE Ratio: 179.44 PB Ratio: 4.59 GF Score: 74/100

Gilead Sciences Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 09, 2022 / 03:30PM GMT
Release Date Price: $59 (-0.91%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst

Good morning, everyone. Welcome to the third day of Cowen's 42nd Annual Healthcare Conference. My name is Tyler Van Buren. I'm a senior biotech analyst here at Cowen. For this next session, we have a fireside chat with Gilead. It's my pleasure to introduce Andy Dickinson, Gilead's Chief Financial Officer. Andy, thank you very much for joining us here. It's a privilege to have you.

Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO

Thanks for having me. I'm happy to be here. Appreciate the invitation.

Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst

Right. Before we get started, I want to mention to the audience that you can submit questions via the web portal or e-mail me at [email protected] and I'll do my best to get those answered.

Questions & Answers

Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst

So we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot